Clinical Trials
71
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (63 trials with phase data)• Click on a phase to view related trials
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
- Conditions
- Type I Diabetes
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 40
- Registration Number
- NCT06739811
- Locations
- 🇳🇱
Isala Zwolle, Zwolle, Netherlands
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Conditions
- Type 1 Diabetes MellitusType 2 Diabetes Mellitus
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 1500
- Registration Number
- NCT06719531
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸ProSciento, Chula Vista, California, United States
🇺🇸John Muir Health, Concord, California, United States
Smart MDI Study (CIP343)
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 140
- Registration Number
- NCT06645834
- Locations
- 🇧🇪
Antwerp University Hospital, Antwerpen, Belgium
🇧🇪Hospital Universitaire Bruxelles Erasme, Brussels, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 60
- Registration Number
- NCT06604871
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸UCSF The Madison Clinic for Pediatric Diabetes, San Francisco, California, United States
🇺🇸Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 250
- Registration Number
- NCT05714059
- Locations
- 🇺🇸
Medical Investigations, Little Rock, Arkansas, United States
🇺🇸Stanford University, Palo Alto, California, United States
🇺🇸University of California San Francisco (UCSF) The Madison Clinic for Pediatric Diabetes, San Francisco, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next